Scott Ispirescu
Psychiatry · Mission Viejo, CANPI 1023148525
Payments from drug & device makers
Across 439 payments — averaging $23.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Otsuka America Pharmaceutical, Inc.$814
- Neurocrine Biosciences, Inc.$798
- Ironshore Pharmaceuticals Inc.$721
- Takeda Pharmaceuticals U.S.A., Inc.$716
- Axsome Therapeutics, Inc.$578
- plus $5K from 24 others
What the payments were for
- Travel & lodging$220%
- Food & beverage$10,35899%
- Education$741%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 89 | $2,194 |
| Otsuka America Pharmaceutical, Inc. | 32 | $814 |
| Neurocrine Biosciences, Inc. | 23 | $798 |
| Ironshore Pharmaceuticals Inc. | 29 | $721 |
| Takeda Pharmaceuticals U.S.A., Inc. | 41 | $716 |
| Axsome Therapeutics, Inc. | 18 | $578 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 26 | $576 |
| Vanda Pharmaceuticals Inc. | 23 | $401 |
| E.r. Squibb & Sons, L.L.C. | 8 | $371 |
| Teva Pharmaceuticals USA, Inc. | 16 | $368 |
| Lundbeck LLC | 17 | $332 |
| Supernus Pharmaceuticals, Inc. | 15 | $326 |
| Sunovion Pharmaceuticals Inc. | 8 | $249 |
| Adlon Therapeutics L.p. | 13 | $241 |
| Bausch Health US, LLC | 13 | $238 |
| Johnson & Johnson | 9 | $222 |
| Alkermes, Inc. | 9 | $209 |
| Idorsia Pharmaceuticals US Inc | 8 | $208 |
| Corium, LLC | 8 | $184 |
| Tris Pharma Inc | 7 | $151 |
| Eisai Inc. | 7 | $126 |
| Collegium Pharmaceutical, Inc. | 6 | $125 |
| Merck | 3 | $74 |
| Noven Therapeutics, LLC | 3 | $66 |
| Almatica Pharma LLC | 2 | $56 |
| Neos Therapeutics, LP | 2 | $35 |
| Biogen | 1 | $24 |
| Alfasigma USA, Inc. | 1 | $23 |
| Assertio Therapeutics, Inc. | 1 | $16 |
| Harmony Biosciences LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,454 in reported general payments places this provider in the 90th percentile of 4,954 psychiatry providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 16 | $34,111 |
| RexultiBrexpiprazole | 21 | $31,024 |
| AuvelityDextromethorphan Hbr/Bupropion | 27 | $28,291 |
| CaplytaLumateperone Tosylate | 13 | $21,721 |
| TrintellixVortioxetine Hydrobromide | 11 | $5,298 |
| Chlorpromazine Hcl | 24 | $3,956 |
| Olanzapine OdtOlanzapine | 21 | $3,658 |
| Aripiprazole | 35 | $3,179 |
| Quetiapine Fumarate | 110 | $2,643 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 26 | $2,044 |
| Lamotrigine | 105 | $1,108 |
| Bupropion XlBupropion Hcl | 56 | $1,068 |
| Naltrexone Hcl | 19 | $1,045 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 39 | $815 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 40 | $787 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $2,194 | $34,11116 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $814 | $31,02421 claims |
| Axsome Therapeutics, Inc.Auvelity | $578 | $28,29127 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $576 | $21,72113 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $716 | $5,29811 claims |
| Almatica Pharma LLCSertraline Hcl | $56 | $35724 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,954 psychiatry providers in California.
Other psychiatry in Mission Viejo
- Elly LeeIrvine$49.8M
- Daniel ChuehOrange$17.9M
- Eric ChavezSan Diego$15.5M
- Lara ShirikjianTorrance$12.6M
- John DuffySanta Ana$12M
- Marina BusselPlaya Vista$12M
- Sherry SoefjeOceanside$11.9M
- Steven MacinaHuntington Beach$11.1M
- Wakelin McNeelRosemead$11M
- Donald AndersonBanning$10.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.